Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

OTC Naloxone In US: Once Encouraged, Now Stalled

Jul 12 2022

• By Malcolm Spicer

• Source: Shutterstock

Related Content

HRT Reports 'Remarkable Achievement' In OTC Naloxone Phase 1 Clinical Trial Results

Mar 01 2022

Drivers For Allowing OTC Naloxone In US Include Social Justice As Well As Public Health Need

Mar 31 2022

State ‘Workarounds’ To Expand Birth Control Access Leave Work For OTC Sales To Complete

Jul 12 2022

Will Influences Behind US FDA's Delayed Approval For OTC Plan B Also Shadow ‘Plan A’ Switch?

Jul 12 2022

Naloxone OTC Switch Urged By Congressional Coalition Of 30 Democrats And Republicans

Apr 12 2022

Additional Topics

International US States United States Prescription To OTC Switch Politics FDA Advertising, Marketing & Sales Commercial Compliance Consumer Drug Approval Standards Drug Review Drug Safety Ingredients Manufacturing OTC Drugs Policy Regulation Retail Safety Gynecology & Urology

More from Rx-to-OTC Switch

More from Health

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window